Investors need to pay close attention to Bristol-Myers (BMY) stock based on the movements in the options market lately.
Argenx (ARGX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
PRINCETON, N.J., September 06, 2024--Bristol Myers Squibb Employees to Relay Nearly 3,000 Miles Cross-Country Aspiring to Raise Over $1 Million for the V Foundation for Cancer Research